Chimeric Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	5.07	3.05	2.36	18.38	22.41	0
Cash & Short-Term Investments	5.07	3.05	2.36	18.38	22.41	0
Cash Growth	43.76%	29.22%	-87.15%	-17.98%	22410099.00%	-
Accounts Receivable	1.96	0.09	6.66	0.04	-	-
Other Receivables	-	-	-	2.62	0.02	-
Receivables	1.96	0.09	6.66	2.66	0.02	-
Other Current Assets	0.12	0.08	0.33	0.13	0.23	-
Total Current Assets	7.15	3.22	9.35	21.17	22.67	0
Property, Plant & Equipment	-	0	0.01	0.02	0.01	-
Long-Term Investments	-	0.04	0.04	0.04	-	-
Other Intangible Assets	11.52	12.01	12.98	13.65	13.83	-
Total Assets	18.68	15.27	22.38	34.88	36.5	0
Accounts Payable	6.2	3.2	7.41	4.7	2.04	-
Accrued Expenses	1.37	3.24	3.77	1.83	1.06	0.03
Short-Term Debt	-	-	-	-	-	0.03
Other Current Liabilities	2.66	3.66	3.52	2.49	4.26	-
Total Current Liabilities	10.23	10.1	14.69	9.02	7.35	0.06
Other Long-Term Liabilities	2.51	2.71	2.02	0.15	4.02	-
Total Liabilities	12.74	12.8	16.71	9.17	11.37	0.06
Common Stock	68.49	63.51	53.93	51.81	37.37	0
Retained Earnings	-69.42	-66.56	-56.78	-30.86	-15.18	-0.06
Comprehensive Income & Other	6.87	5.52	8.51	4.76	2.94	-
Shareholders' Equity	5.94	2.47	5.66	25.71	25.13	-0.06
Total Liabilities & Equity	18.68	15.27	22.38	34.88	36.5	0
Total Debt	-	-	-	-	-	0.03
Net Cash (Debt)	5.07	3.05	2.36	18.38	22.41	-0.03
Net Cash Growth	43.76%	29.22%	-87.15%	-17.98%	-	-
Net Cash Per Share	0.01	0.00	0.01	0.05	0.12	-
Filing Date Shares Outstanding	1,575	905.15	529.4	425.28	330.86	-
Total Common Shares Outstanding	1,575	876.06	506.69	425.28	330.86	-
Working Capital	-3.07	-6.87	-5.34	12.15	15.31	-0.06
Book Value Per Share	0.00	0.00	0.01	0.06	0.08	-
Tangible Book Value	-5.58	-9.54	-7.32	12.05	11.3	-0.06
Tangible Book Value Per Share	-0.00	-0.01	-0.01	0.03	0.03	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.